Cramer's 'Mad Money' Recap: Jet Set Ideas

Passing the Drug Test

The New York Times ran a story on a drug test in Britain that nearly killed six participants, and that report led Cramer to wonder which companies conduct drug tests right.

The best-of-breed company for clinical trials, he said, is Pharmaceutical Product Development(PPDI), which he called the best contract research organization on earth.

The company reported 27% earnings growth last quarter, and Cramer said that's "almost Google-licious."

Pharmaceutical Product Development also does more than testing. It takes a stake in the drugs it believes will work, runs phase I, II and III clinical trials and manages data from studies. The company also runs postmarket registries for dangerous drugs and does some marketing, he said.

He said that he wouldn't have recommended the stock a week ago, but now that C.R. Bard(BCR) and Quest Diagnostics(DGX) have reported and their stocks moved up, he thinks now could be a good time to buy Pharmaceutical Product Development.

The company also has some good contracts, including a five-year deal to run clinical research on HIV, as well as testing on diabetes and premature ejaculation treatments.

Caribbean Cruising

Cramer said that he used to believe that Royal Caribbean(RCL) should trade at a discount to rival Carnival(CCL), based on the belief that Carnival is a more reliable company.

But this week Royal Caribbean reported a quarter so good that he changed his mind; and the company's president, Adam Goldstein, joined Cramer to discuss his company's most recent earnings report.

Goldstein said that, overall, the Caribbean will remain a healthy region.

Cramer pointed out that Carnival said business in the area is bad, but Goldstein said that his company sees growth in the Caribbean, even though it has been a "sensitive" segment of its business.

Goldstein added that his company has gotten more money from passengers by ratcheting up onboard spending.

To view Cramer's interview with Goldstein, please click here.

Lightning Round

Cramer was bullish on Goldcorp(GG), Cephalon(CEPH), Crystallex International(KRY), Yahoo!(YHOO), Matsushita(MC), Corning(GLW) and UnitedHealth Group(UNH).

Cramer was bearish on Tanzanian Royalty Exploration(TRE), Deckers Outdoor(DECK), MedImmune(MEDI), Pozen(POZN), International DisplayWorks(IDWK), Jabil Circuit(JBL), Zoltek Companies(ZOLT), Travelzoo(TZOO) and Bowater(BOW).

For more of Cramer's insights during the Lightning Round, click here.

---

Want more Cramer? Check out Jim's rules and commandments for investing from his latest book by clicking here.

Here's your chance to pick the stock you'd like me to feature on my radio show April 27: Citrix eBay Energy Partners Motorola Pacific Ethanol Valero Energy

REMEMBER to listen in on Thursday for my take on the stock that wins this poll!

>To order reprints of this article, click here: Reprints